A retrospective cohort at a tertiary rhinology clinic identified 41 focal submucosal lesions of the anterior inferior turbinate among 14,103 nasal endoscopies (0.3%). The cohort skewed older, with a mean age of 51.5 years, and predominantly male (75.6%). Symptom duration varied widely; the median was 36 months. Rhinorrhea and nasal obstruction were the most common presenting complaints, and 15 of 41 patients reported allergic disease. Four patients had extra-nasal involvement documented during systemic evaluation. Investigators performed biopsies selectively in lesions showing mucosal disruption such as crusting or bleeding; 18 biopsies were obtained and analyzed histologically and immunohistochemically.
Endoscopic appearance was consistent across cases: yellowish, sessile, submucosal masses in the anterior inferior turbinate. Many lesions had intact overlying mucosa; a subset displayed hemorrhagic crusting prompting biopsy. All 18 sampled lesions demonstrated dense lymphoplasmacytic infiltrates on H&E staining. Lymphoid follicle formation appeared in 8 of 18 biopsies. Fibrosis was present in 10 biopsies, but none showed storiform-pattern fibrosis. Obliterative phlebitis was not observed in any specimen.
Immunohistochemistry revealed abundant CD3-positive T cells, CD20-positive B cells, and variable but often high numbers of IgG- and IgG4-positive plasma cells. Ki-67 staining localized to CD20-positive B-cell areas. Measured counts showed a median IgG4 cell count and an IgG4/IgG ratio that exceeded 40% in 10 of 18 biopsies, meeting the immunohistochemical cutoff commonly used to support an IgG4-RD diagnosis. Investigators noted, however, that the distinctive histologic structural features required to define systemic IgG4-related disease—storiform fibrosis and obliterative phlebitis—were absent.
All patients met the entry criterion for the 2019 ACR/EULAR classification based on a lymphoid mass, and none met the published exclusion items. Despite frequent IgG4-positive plasma cells, only two of the 41 patients were classified as IgG4-RD by the 2019 ACR/EULAR algorithm; both of those cases had documented extra-nasal disease. One of these patients had pancreatitis and parotid enlargement with a serum IgG4 slightly above the local upper limit; the other had multisite extra-nasal involvement including lacrimal and pituitary lesions.
The team also applied the 2011 comprehensive diagnostic criteria to the 18 biopsied patients. Outcomes under that scheme were heterogeneous: 2 patients met criteria for definite IgG4-RD, 7 were probable, and 9 were possible. The disparity between immunohistologic positivity and fulfillment of formal classification or comprehensive diagnostic criteria formed a central observation of the report.
Treatment was individualized by the primary physician. Of 41 patients, 18 received active therapy for substantial symptoms: 10 underwent surgical excision, 4 received systemic corticosteroid therapy, and 4 received combined surgery and corticosteroids. The remaining 23 patients were observed without immediate intervention.
Surgical resection produced symptom control with minimal recurrence: 9 of 10 surgically treated patients had no recurrence during the reported follow-up. Corticosteroid monotherapy had variable effectiveness; 2 of 4 patients improved. Combined surgery plus corticosteroids yielded improvement in 2 of 4 patients. Among the conservatively observed group, spontaneous improvement occurred in 5 of 23 patients (21.7%); the other 18 showed persistent but clinically stable lesions without progression during follow-up. The two patients who met 2019 ACR/EULAR criteria for IgG4-RD were managed medically; the younger patient responded to corticosteroids and additional immunosuppression (including rituximab as noted by the investigators), whereas the older patient's extra-nasal disease responded but nasal symptoms did not.
The authors framed these inferior turbinate masses as likely representing a localized, benign lymphoid hyperplasia that is often IgG4-rich yet histologically distinct from systemic IgG4-related disease because storiform fibrosis and obliterative phlebitis were absent. Important limitations were documented: this was a single-center retrospective study with biopsies performed selectively when mucosal damage was present, so sampling bias may affect reported histologic frequencies. The source did not report standardized corticosteroid dosing regimens or uniform surgical techniques; treatment decisions were at physicians' discretion. Long-term outcome data beyond the described follow-up intervals were limited. The investigators called for further studies to define the lesions' pathophysiology, to determine optimal management strategies, and to establish long-term natural history and recurrence risk.